147 related articles for article (PubMed ID: 7791475)
41. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
42. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
Schippinger W; Samonigg H; Schaberl-Moser R; Greil R; Thödtmann R; Tschmelitsch J; Jagoditsch M; Steger GG; Jakesz R; Herbst F; Hofbauer F; Rabl H; Wohlmuth P; Gnant M; Thaler J;
Br J Cancer; 2007 Oct; 97(8):1021-7. PubMed ID: 17895886
[TBL] [Abstract][Full Text] [Related]
43. Enhanced cytotoxicity of 5-fluorouracil combined with [6RS]leucovorin and recombinant human interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Adkins DA; Houghton PJ
Adv Exp Med Biol; 1993; 339():133-42; discussion 165-7. PubMed ID: 8178712
[No Abstract] [Full Text] [Related]
44. [Systemic palliative chemotherapy with 5-fluorouracil and leucovorin in disseminated colorectal cancer].
Wiboltt K; Raskov HH
Ugeskr Laeger; 1999 Jun; 161(25):3827-32. PubMed ID: 10412300
[TBL] [Abstract][Full Text] [Related]
45. [Progression of adjuvant chemotherapy for colon cancer].
He YJ; Dong QM; Li YH
Ai Zheng; 2005 Dec; 24(12):1546-9. PubMed ID: 16351811
[TBL] [Abstract][Full Text] [Related]
46. UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer.
Smith R; Wickerham DL; Wieand HS; Colangelo L; Mamounas EP
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):44-7. PubMed ID: 10442360
[TBL] [Abstract][Full Text] [Related]
47. Pancreatic metastasis from colon carcinoma treated with radiotherapy with palliative benefit.
Saif MW; Kaley K
JOP; 2010 Nov; 11(6):644-5; author reply 650. PubMed ID: 21068505
[No Abstract] [Full Text] [Related]
48. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
[TBL] [Abstract][Full Text] [Related]
49. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.
Sargent DJ; Goldberg RM; Jacobson SD; Macdonald JS; Labianca R; Haller DG; Shepherd LE; Seitz JF; Francini G
N Engl J Med; 2001 Oct; 345(15):1091-7. PubMed ID: 11596588
[TBL] [Abstract][Full Text] [Related]
50. [Chemotherapy in cancers of the colon].
Seitz JF
Gastroenterol Clin Biol; 1993; 17(2 Pt 3):T2-12. PubMed ID: 7686868
[No Abstract] [Full Text] [Related]
51. [Adjuvant treatment for colon carcinoma. Results and perspectives].
Wein A; Riedel C; Lehnert T; Wakker R; Reingruber B; Teichmann W; Kohnen R; Herfarth C; Hohenberger W; Hahn EG
Dtsch Med Wochenschr; 1998 May; 123(21):674-80. PubMed ID: 9638096
[No Abstract] [Full Text] [Related]
52. [Adjuvant systemic chemo- or immunotherapy of colon cancer].
Schlag PM
Chirurg; 1994 Jun; 65(6):503-8. PubMed ID: 8088205
[TBL] [Abstract][Full Text] [Related]
53. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer.
Erlichman C; Fine S
J Clin Oncol; 1987 Sep; 5(9):1492-3. PubMed ID: 3305796
[No Abstract] [Full Text] [Related]
54. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
[TBL] [Abstract][Full Text] [Related]
55. Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.
Zaanan A; Fléjou JF; Emile JF; Des GG; Cuilliere-Dartigues P; Malka D; Lecaille C; Validire P; Louvet C; Rougier P; de Gramont A; Bonnetain F; Praz F; Taïeb J
Clin Cancer Res; 2011 Dec; 17(23):7470-8. PubMed ID: 21998335
[TBL] [Abstract][Full Text] [Related]
56. [Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial].
Kubicka S
Strahlenther Onkol; 2016 Jul; 192(7):505-6. PubMed ID: 27272658
[No Abstract] [Full Text] [Related]
57. Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience.
Kim CA; Spratlin JL; Armstrong DE; Ghosh S; Mulder KE
Clin Colorectal Cancer; 2014 Sep; 13(3):199-206. PubMed ID: 25088184
[TBL] [Abstract][Full Text] [Related]
58. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
Chua YJ; Zalcberg JR
Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
[TBL] [Abstract][Full Text] [Related]
59. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
[TBL] [Abstract][Full Text] [Related]
60. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.
Kumar A; Peixoto RD; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Speers CH; Cheung WY
Clin Colorectal Cancer; 2015 Dec; 14(4):262-8.e1. PubMed ID: 26123496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]